Follow
Masahiro Marshall Nakagawa
Masahiro Marshall Nakagawa
Verified email at kyoto-u.ac.jp
Title
Cited by
Cited by
Year
Age-related remodelling of oesophageal epithelia by mutated cancer drivers
A Yokoyama, N Kakiuchi, T Yoshizato, Y Nannya, H Suzuki, Y Takeuchi, ...
Nature 565 (7739), 312-317, 2019
5492019
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation
T Yoshizato, Y Nannya, Y Atsuta, Y Shiozawa, Y Iijima-Yamashita, ...
Blood, The Journal of the American Society of Hematology 129 (17), 2347-2358, 2017
3122017
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity
Y Kagoya, A Yoshimi, K Kataoka, M Nakagawa, K Kumano, S Arai, ...
The Journal of clinical investigation 124 (2), 528-542, 2014
2352014
Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells
S Goyama, J Schibler, L Cunningham, Y Zhang, Y Rao, N Nishimoto, ...
The Journal of clinical investigation 123 (9), 3876-3888, 2013
2262013
Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity
K Kataoka, T Sato, A Yoshimi, S Goyama, T Tsuruta, H Kobayashi, ...
Journal of Experimental Medicine 208 (12), 2403-2416, 2011
2022011
Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis
N Kakiuchi, K Yoshida, M Uchino, T Kihara, K Akaki, Y Inoue, K Kawada, ...
Nature 577 (7789), 260-265, 2020
1942020
Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling
Y Watatani, Y Sato, H Miyoshi, K Sakamoto, K Nishida, Y Gion, Y Nagata, ...
Leukemia 33 (12), 2867-2883, 2019
1882019
Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins
A Yoshimi, S Goyama, N Watanabe-Okochi, Y Yoshiki, Y Nannya, E Nitta, ...
Blood, The Journal of the American Society of Hematology 117 (13), 3617-3628, 2011
1742011
A role for RUNX1 in hematopoiesis and myeloid leukemia
M Ichikawa, A Yoshimi, M Nakagawa, N Nishimoto, N Watanabe-Okochi, ...
International journal of hematology 97, 726-734, 2013
1452013
AML1/Runx1 rescues Notch1-null mutation-induced deficiency of para-aortic splanchnopleural hematopoiesis
M Nakagawa, M Ichikawa, K Kumano, S Goyama, M Kawazu, T Asai, ...
Blood 108 (10), 3329-3334, 2006
1232006
AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis
M Ichikawa, S Goyama, T Asai, M Kawazu, M Nakagawa, M Takeshita, ...
The Journal of Immunology 180 (7), 4402-4408, 2008
1162008
Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells
S Arai, A Yoshimi, M Shimabe, M Ichikawa, M Nakagawa, Y Imai, ...
Blood, The Journal of the American Society of Hematology 117 (23), 6304-6314, 2011
1152011
Recurrent CDC25C mutations drive malignant transformation in FPD/AML
A Yoshimi, T Toya, M Kawazu, T Ueno, A Tsukamoto, H Iizuka, ...
Nature communications 5 (1), 4770, 2014
1012014
Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis
R Saiki, Y Momozawa, Y Nannya, MM Nakagawa, Y Ochi, T Yoshizato, ...
Nature medicine 27 (7), 1239-1249, 2021
942021
Molecular classification and diagnostics of upper urinary tract urothelial carcinoma
Y Fujii, Y Sato, H Suzuki, N Kakiuchi, T Yoshizato, AT Lenis, S Maekawa, ...
Cancer Cell 39 (6), 793-809. e8, 2021
862021
Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice
A Kon, S Yamazaki, Y Nannya, K Kataoka, Y Ota, MM Nakagawa, ...
Blood, The Journal of the American Society of Hematology 131 (6), 621-635, 2018
822018
In vivo alemtuzumab enables haploidentical human leukocyte antigen-mismatched hematopoietic stem-cell transplantation without ex vivo graft manipulation
Y Kanda, K Oshima, Y Asano-Mori, K Kandabashi, M Nakagawa, ...
Transplantation 79 (10), 1351-1357, 2005
802005
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms
H Makishima, R Saiki, Y Nannya, S Korotev, C Gurnari, J Takeda, ...
Blood 141 (5), 534-549, 2023
772023
The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region
S Goyama, Y Yamaguchi, Y Imai, M Kawazu, M Nakagawa, T Asai, ...
Blood 104 (12), 3558-3564, 2004
682004
AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors
M Nakagawa, M Shimabe, N Watanabe-Okochi, S Arai, A Yoshimi, ...
Blood, The Journal of the American Society of Hematology 118 (25), 6626-6637, 2011
652011
The system can't perform the operation now. Try again later.
Articles 1–20